The Role of Signal Transduction Pathways in Hypertension

信号转导途径在高血压中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The goal of the planned research is to either confirm or refute the presence of separate phosphatidylinositol 3 (PI3) and mitogen-activated protein (MAP) kinase pathways in the nucleus tract solitarius (NTS) in various models of hypertension. The overall objective is to investigate the signaling mechanisms at this brain site potentially contributing to development and maintenance of sustained hypertension. Our ongoing studies are designed to provide initial information about the relationship between the apparent enhancement of the sympathetic nervous system in various forms of hypertension and the role of PI3 and MAP kinase signaling pathways in the maintenance of hypertension. Our initial goal is to demonstrate that PI3 and MAP kinase signaling pathways in the NTS of (mRen-2)27 transgenic rats are activated in response to Ang II binding to AT1 receptors. The rationale for the proposed research is that, once knowledge of the mechanisms that are responsible for the development of hypertension has been obtained, it may lead to new strategies that can be used to prevent and/or treat hypertension, thereby reducing the morbidity and mortality associated with high blood pressure.
描述(申请人提供):计划中的研究的目标是证实或否认在各种高血压模型的孤立核(NTS)中存在不同的磷脂酰肌醇3(PI3)和丝裂原激活蛋白(MAP)激酶通路。总体目标是研究这个大脑部位的信号机制,这些信号机制可能有助于持续性高血压的发展和维持。我们正在进行的研究旨在提供关于各种形式的高血压患者交感神经系统明显增强与PI3和MAPK信号通路在高血压维持中的作用之间的关系的初步信息。我们的初步目标是证明(MREN-2)27只转基因大鼠NTS中的PI3和MAP激酶信号通路在Ang II与AT1受体结合的反应中被激活。这项拟议研究的理由是,一旦了解了导致高血压发展的机制,就可能产生可用于预防和/或治疗高血压的新策略,从而降低与高血压相关的发病率和死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Exazevia M Logan其他文献

Exazevia M Logan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Exazevia M Logan', 18)}}的其他基金

The Role of Signal Transduction Pathways in Hypertension
信号转导途径在高血压中的作用
  • 批准号:
    7281775
  • 财政年份:
    2006
  • 资助金额:
    $ 4.19万
  • 项目类别:

相似海外基金

Exploratory Efficacy-Evaluation Study of Angiotensin Receptor-Neprilysin Inhibitor in patients with dialysis
血管紧张素受体脑啡肽酶抑制剂在透析患者中​​的探索性疗效评价研究
  • 批准号:
    21K16191
  • 财政年份:
    2021
  • 资助金额:
    $ 4.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
慢性肾脏病的个体化血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂治疗
  • 批准号:
    10313873
  • 财政年份:
    2021
  • 资助金额:
    $ 4.19万
  • 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
  • 批准号:
    10469311
  • 财政年份:
    2020
  • 资助金额:
    $ 4.19万
  • 项目类别:
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis - a Randomized Controlled Trial
血管紧张素受体阻滞剂对主动脉瓣狭窄的影响 - 一项随机对照试验
  • 批准号:
    433568
  • 财政年份:
    2020
  • 资助金额:
    $ 4.19万
  • 项目类别:
    Operating Grants
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
  • 批准号:
    10649490
  • 财政年份:
    2020
  • 资助金额:
    $ 4.19万
  • 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
  • 批准号:
    10210299
  • 财政年份:
    2020
  • 资助金额:
    $ 4.19万
  • 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
  • 批准号:
    10065083
  • 财政年份:
    2020
  • 资助金额:
    $ 4.19万
  • 项目类别:
Mechanism of suppressive effects for atherosclerosis by Angiotensin Receptor-Neprilysin Inhibitor
血管紧张素受体脑啡肽酶抑制剂抑制动脉粥样硬化的机制
  • 批准号:
    19K17618
  • 财政年份:
    2019
  • 资助金额:
    $ 4.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathophysiological significance of angiotensin receptor-binding protein in leucocytes and immune cells
白细胞和免疫细胞中血管紧张素受体结合蛋白的病理生理意义
  • 批准号:
    19K17575
  • 财政年份:
    2019
  • 资助金额:
    $ 4.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
AgRP 神经元中血管紧张素受体 G 蛋白信号转换在心脏代谢控制中的作用
  • 批准号:
    10658260
  • 财政年份:
    2017
  • 资助金额:
    $ 4.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了